Sapporo Clinical Laboratory (SSE:9776) EPS (Basic): 円157.88 (TTM As of Sep. 2025)


SSE:9776 Sapporo Clinical Laboratory Inc SSE:9776
66 GF Score
Price 円2,124.00
GF Value 円1,128.61
! 4 Warning Signs
View Full Analysis

What is Sapporo Clinical Laboratory EPS (Basic)?

Sapporo Clinical Laboratory SSE:9776 66 EPS (Basic) is 円157.88 as of Sep. 2025. GuruFocus rates SSE:9776 with a GF Score™ of 66/100 and a GF Value™ of 円1,128.61. The stock has 4 warning signs investors should review.

Sapporo Clinical Laboratory's basic earnings per share (Basic EPS) for the six months ended in Sep. 2025 was 円80.40. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Sep. 2025 was 円157.88.

Sapporo Clinical Laboratory's EPS (Diluted) for the six months ended in Sep. 2025 was 円80.40. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Sep. 2025 was 円157.88.

Sapporo Clinical Laboratory's EPS without NRI for the six months ended in Sep. 2025 was 円80.42. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Sep. 2025 was 159.66.

During the past 12 months, Sapporo Clinical Laboratory's average EPS without NRIGrowth Rate was 25.70% per year. During the past 3 years, the average EPS without NRI Growth Rate was -22.80% per year. During the past 5 years, the average EPS without NRI Growth Rate was -9.90% per year. During the past 10 years, the average EPS without NRI Growth Rate was -4.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Sapporo Clinical Laboratory's highest 3-Year average EPS without NRI Growth Rate was 29.20% per year. The lowest was -23.80% per year. And the median was 6.00% per year.

Sapporo Clinical Laboratory  (SSE:9776) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Sapporo Clinical Laboratory EPS (Basic) Related Terms

Sapporo Clinical Laboratory EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Sapporo Clinical Laboratory's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sapporo Clinical Laboratory EPS (Basic) Chart

Sapporo Clinical Laboratory Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 231.85 306.16 170.53 114.14 148.35

Sapporo Clinical Laboratory Semi-Annual Data
Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 67.94 46.20 70.87 77.48 80.40
SSE:9776
66GF Score
Sapporo Clinical Laboratory Inc SSE:9776
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sapporo Clinical Laboratory EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Sapporo Clinical Laboratory's Basic EPS for the fiscal year that ended in Mar. 2025 is calculated as

Basic EPS (A: Mar. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(464.176-0)/3.129
=148.35

Sapporo Clinical Laboratory's Basic EPS for the quarter that ended in Sep. 2025 is calculated as

Basic EPS (Q: Sep. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(250.812-0)/3.119
=80.41

EPS (Basic) for the trailing twelve months (TTM) ended in Sep. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was 円157.88

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of 円157.88 mean?
Sapporo Clinical Laboratory (SSE:9776) has a EPS (Basic) of 円157.88 as of Sep. 2025. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Sapporo Clinical Laboratory and its competitors.
Is Sapporo Clinical Laboratory's EPS (Basic) too high?
Sapporo Clinical Laboratory's current EPS (Basic) is 円157.88. Overall, Sapporo Clinical Laboratory has a GF Score™ of 66/100, reflecting its overall financial health beyond just this single metric.
How does Sapporo Clinical Laboratory's EPS (Basic) compare to competitors?
Sapporo Clinical Laboratory's EPS (Basic) of 円157.88 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Healthcare Providers & Services company?
A good EPS (Basic) depends on the Healthcare Providers & Services industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Sapporo Clinical Laboratory and its competitors. Sapporo Clinical Laboratory's current EPS (Basic) is 円157.88. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sapporo Clinical Laboratory stock overvalued right now?
Sapporo Clinical Laboratory (SSE:9776) has a current EPS (Basic) of 円157.88. The stock's GF Value™ is 円1,128.61, compared to a current price of 円2,124.00 — trading 88.2% above its estimated fair value. The current EPS (Basic) is 円157.88. Sapporo Clinical Laboratory's overall GF Score™ is 66/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Sapporo Clinical Laboratory (SSE:9776), the current EPS (Basic) is 円157.88 as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sapporo Clinical Laboratory (SSE:9776) Overvalued in 2026?

Based on GuruFocus' analysis, Sapporo Clinical Laboratory stock appears to be overvalued. The current stock price of 円2,124.00 is trading 88.2% above its estimated GF Value™ of 円1,128.61.

Key valuation signals for SSE:9776:

  • EPS (Basic): 円157.88
  • GF Value™: 円1,128.61 vs. price of 円2,124.00 (88.2% above fair value)
  • GF Score™: 66/100 with 4 warning signs

No single metric tells the full story. See the SSE:9776 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sapporo Clinical Laboratory Business Description

Address 18-9-1 Nishi Kita-Gojo, Chuo-ku Sapporo, Hokkaido, Sapporo, JPN, 060 0005
Sapporo Clinical Laboratory Inc. is a Japan based company engaged in offering clinical testing services. Its portfolio of services covers clinical examination, pathological examination, dispensing pharmacy, food hygiene environmental test, and radiation management. It is also engaged in the development of an integrated system for clinical testing.
66GF Score

Get the complete analysis for SSE:9776

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円2,124.00
Price
円1,128.61
GF Value